← Back to Patent Explorer
US6537272B2 Expired / Lapsed US ⏱️ 0.0 years remaining

Apparatus and method for creating, maintaining, and controlling a virtual electrode used for the ablation of tissue

Assignee: Medtronic Inc
•
Filing: 2001-11-30
•
Granted: 2003-03-25
•
Expires: 2021-11-30
📄 Original PDF 🌐 Google Patents 🔄 Sync Now

Abstract

Abstract The present invention provides an apparatus and a method for producing a virtual electrode within or upon a tissue to be treated with radio frequency alternating electric current, such tissues including but not limited to brain, liver, cardiac, prostate, breast, and vascular tissues and neoplasms. An apparatus in accordance with the present invention includes a source of super-cooled fluid for selectively providing super-cooled fluid to the target tissue to cause a temporary cessation of cellular or electrical activity, a supply of conductive or electrolytic fluid to be provided to the target tissue, and alternating current generator, and a processor for creating, maintaining, and controlling the ablation process by the interstitial or surficial delivery of the fluid to a tissue and the delivery of electric power to the tissue via the virtual electrode. A method in accord with the present invention includes delivering super-cooled fluid to the target tissue to cause a temporary cessation of cellular or electrical activity, evaluating whether the temporary cessation of cellular or electrical activity is the desired cessation of cellular or electrical activity, and if so, delivering a conductive fluid to the predetermined tissue ablation site for a predetermined time period, applying a predetermined power level of radio frequency current to the tissue, monitoring at least one of several parameters, and adjusting either the applied power and/or the fluid flow in response to the measured parameters.

Inventors

  • 👤 Mark A. Christopherson
  • 👤 Chike O. Onyekaba

Bibliographic Details

Application Number —
Jurisdiction US
Data Source google_patents
Last Synchronized 2026-10-23 19:36
CPC Classifications
A; A61; A61B; A61B18/00; A61B18/04; A61B18/12; A61B18/14; A61B18/1206; A61B18/1233; A61B2018/00005; A61B2018/00011; A61B2018/00029; A61B2018/00636; A61B2018/00696; A61B2018/00702; A61B2018/00708; A61B2018/00773; A61B2018/00791; A61B2018/00797; A61B2018/00821; A61B2018/00875; A61B2018/1472

Claims Analysis

Total Claims: 28
Claim 1
Independent Claim 308 words
An apparatus for producing, maintaining, and controlling a virtual electrode for a provision of RF current therapy through the virtual electrode to a target tissue of a body of a patient, the apparatus providing a conductive fluid and an RF current via at least one surgical instrument to the target tissue to create the virtual electrode, the apparatus comprising: a) at least one source of super-cooled fluid for selectively providing super-cooled fluid to the target tissue to cause a temporary cessation of cellular or electrical activity; b) at least one source of conductive fluid for selectively providing conductive fluid to the target tissue; c) a generator of RF current, the generator supplying the RF current to the virtual electrode via the surgical instrument; e) means for detecting an electrical arc; f) means for measuring the impedance of the body of the patient to the passage of the RF current; g) at least one primary temperature sensor for sensing the temperature at a first predetermined location in the body of the patient; h) means for controlling a rate of application of the super-cooled fluid and a rate of application of the conductive fluid to the target tissue and for controlling a power level of the RF current, the means for controlling receiving arc detection signals from the arc detection means, impedance measurement signals from the impedance measuring means, and temperature measurement signals from the at least one temperature sensor, the rate of super-cooled fluid flow controlled in response to the sensed temperature, the power level of the RF current and the rate of conductive fluid flow controlled by the controlling means in response to changes in the measured impedance and the sensed temperature, the means for controlling discontinuing the application of RF current for a predetermined period of time upon receiving signals indicating a detection of an electrical arc.
Claim 2
Independent Claim 308 words
An apparatus for producing, maintaining, and controlling a virtual electrode for a provision of RF current therapy through the virtual electrode to a target tissue of a body of a patient, the apparatus providing a conductive fluid and an RF current via at least one surgical instrument to the target tissue to create the virtual electrode, the apparatus comprising: a) at least one source of super-cooled fluid for selectively providing super-cooled fluid to the target tissue to cause a temporary cessation of cellular or electrical activity; b) at least one source of conductive fluid for selectively providing conductive fluid to the target tissue; c) a generator of RF current, the generator supplying the RF current to the virtual electrode via the surgical instrument; e) means for detecting an electrical arc; f) means for measuring the impedance of the body of the patient to the passage of the RF current; g) at least one primary temperature sensor for sensing the temperature at a first predetermined location in the body of the patient; h) means for controlling a rate of application of the super-cooled fluid and a rate of application of the conductive fluid to the target tissue and for controlling a power level of the RF current, the means for controlling receiving arc detection signals from the arc detection means, impedance measurement signals from the impedance measuring means, and temperature measurement signals from the at least one temperature sensor, the rate of super-cooled fluid flow controlled in response to the sensed temperature, the power level of the RF current and the rate of conductive fluid flow controlled by the controlling means in response to changes in the measured impedance and the sensed temperature, the means for controlling discontinuing the application of RF current for a predetermined period of time upon receiving signals indicating a detection of an electrical arc.
Claim 3
Dependent Claim 28 words
The apparatus of claim 1 wherein said predetermined time for discontinuing the RF power in response to the detection of an electrical arc is at least two seconds.
Claim 4
Dependent Claim 52 words
The apparatus of claim 1 and further including means for determining time and means for counting the number of arcs detected by the arc detection means, the means for controlling discontinuing the application of the RF current to the patient upon counting a predetermined number of arcs within a predetermined time period.
Claim 5
Dependent Claim 44 words
The apparatus of claim 1 and further including a clock, said clock providing time indicating signals to said means for controlling, wherein said means for controlling determining the time interval between successive changes in the maximum RF power based upon said time indicating signals.
Claim 6
Dependent Claim 32 words
The apparatus of claim 4 wherein the means for controlling maintains the current maximum RF power if a predetermined time interval has not elapsed since the most recent change to RF power.
Claim 7
Dependent Claim 47 words
The apparatus of claim 1 wherein the means for controlling determines a rate of change of the measured impedance and compares it with a predetermined impedance threshold, the means for controlling reducing the maximum RF power by a predetermined amount if such predetermined impedance threshold is exceeded.
Claim 8
Dependent Claim 75 words
The apparatus of claim 1 and further comprising: at least one secondary temperature sensor being disposed at a predetermined location in the body of the patient, wherein the at least one secondary temperature sensor provides temperature indicating signals to the means for controlling; and wherein the means for controlling compares the secondary temperature measurements with a predetermined secondary temperature threshold and discontinues the application of RF power if the predetermined secondary temperature threshold is exceeded.
Claim 9
Dependent Claim 18 words
The apparatus of claim 1 wherein the means for controlling also controls the temperature of the super-cooled fluid.
Claim 10
Independent Claim 324 words
A system for producing, maintaining, and controlling a virtual electrode for a provision of RF current therapy through the virtual electrode to a target tissue of a patient, the system providing a conductive fluid and an RF current via at least one surgical instrument to the target tissue to create the virtual electrode, the apparatus comprising: a) at least one source of super-cooled fluid for selectively providing super-cooled fluid to the target tissue to cause a temporary cessation of cellular or electrical activity; b) at least one source of conductive fluid for selectively providing conductive fluid to the target tissue; c) a surgical instrument including an electrode for delivery of the RF current to the virtual electrode; d) a generator of RF current, the generator supplying the RF current to the virtual electrode via the surgical instrument; e) means for detecting an electrical arc; f) means for measuring the impedance of the body of the patient to the passage of the RF current; g) at least one primary temperature sensor for sensing the temperature at at least a first predetermined location in the body of the patient; h) means for controlling a rate of application of the super-cooled fluid and a rate of application of the conductive fluid to the target tissue and for controlling a power level of the RF current, the means for controlling receiving arc detection signals from the arc detection means, impedance measurement signals from the impedance measuring means, and temperature measurement signals from the at least one temperature sensor, the rate of super-cooled fluid flow controlled in response to the sensed temperature, the power level of the RF current and the rate of conductive fluid flow controlled by the controlling means in response to changes in the measured impedance and the sensed temperature, the means for controlling discontinuing the application of RF current for a predetermined period of time upon receiving signals indicating a detection of an electrical arc.
Claim 11
Independent Claim 324 words
A system for producing, maintaining, and controlling a virtual electrode for a provision of RF current therapy through the virtual electrode to a target tissue of a patient, the system providing a conductive fluid and an RF current via at least one surgical instrument to the target tissue to create the virtual electrode, the apparatus comprising: a) at least one source of super-cooled fluid for selectively providing super-cooled fluid to the target tissue to cause a temporary cessation of cellular or electrical activity; b) at least one source of conductive fluid for selectively providing conductive fluid to the target tissue; c) a surgical instrument including an electrode for delivery of the RF current to the virtual electrode; d) a generator of RF current, the generator supplying the RF current to the virtual electrode via the surgical instrument; e) means for detecting an electrical arc; f) means for measuring the impedance of the body of the patient to the passage of the RF current; g) at least one primary temperature sensor for sensing the temperature at at least a first predetermined location in the body of the patient; h) means for controlling a rate of application of the super-cooled fluid and a rate of application of the conductive fluid to the target tissue and for controlling a power level of the RF current, the means for controlling receiving arc detection signals from the arc detection means, impedance measurement signals from the impedance measuring means, and temperature measurement signals from the at least one temperature sensor, the rate of super-cooled fluid flow controlled in response to the sensed temperature, the power level of the RF current and the rate of conductive fluid flow controlled by the controlling means in response to changes in the measured impedance and the sensed temperature, the means for controlling discontinuing the application of RF current for a predetermined period of time upon receiving signals indicating a detection of an electrical arc.
Claim 12
Dependent Claim 28 words
The system of claim 9 wherein said predetermined time for discontinuing the RF power in response to the detection of an electrical arc is at least two seconds.
Claim 13
Dependent Claim 52 words
The system of claim 9 and further including means for determining time and means for counting the number of arcs detected by the arc detection means, the means for controlling discontinuing the application of the RF current to the patient upon counting a predetermined number of arcs within a predetermined time period.
Claim 14
Dependent Claim 44 words
The system of claim 9 and further including a clock, said clock providing time indicating signals to said means for controlling, wherein said means for controlling determining the time interval between successive changes in the maximum RF power based upon said time indicating signals.
Claim 15
Dependent Claim 32 words
The system of claim 12 wherein the means for controlling maintains the current maximum RF power if a predetermined time interval has not elapsed since the most recent change to RF power.
Claim 16
Dependent Claim 47 words
The system of claim 9 wherein the means for controlling determines a rate of change of the measured impedance and compares it with a predetermined impedance threshold, the means for controlling reducing the maximum RF power by a predetermined amount if such predetermined impedance threshold is exceeded.
Claim 17
Dependent Claim 75 words
The system of claim 9 and further comprising: at least one secondary temperature sensor being disposed at a predetermined location in the body of the patient, wherein the at least one secondary temperature sensor provides temperature indicating signals to the means for controlling; and wherein the means for controlling compares the secondary temperature measurements with a predetermined secondary temperature threshold and discontinues the application of RF power if the predetermined secondary temperature threshold is exceeded.
Claim 18
Independent Claim 187 words
A method for treating tissue by ablation with a virtual electrode, the method comprising: (a) placing an RF power delivery electrode in contact with target tissue of a patient; (b) providing the tissue with a super-cooled fluid to cause a temporary cessation of cellular or electrical activity; (c) evaluating the effect of the distributed super-cooled fluid, including whether the providing of the super-cooled fluid to the target tissue causes a temporary cessation of cellular activity or electrical activity indicative of the disorder or tumor, or a temporary cessation of cellular activity or electrical activity indicative of a temporary adverse side effect; (d) providing the tissue with a conductive fluid to create a virtual electrode; (e) applying RF current to the tissue through the virtual electrode while continuing to provide conductive fluid to the tissue; (f) monitoring an impedance of the tissue; (g) determining a rate of change of the tissue impedance within a predetermined time interval; and (h) increasing a size of the virtual electrode when the determined rate of change of tissue impedance exceeds a predetermined value by increasing a flow rate of the conductive fluid.
Claim 19
Independent Claim 187 words
A method for treating tissue by ablation with a virtual electrode, the method comprising: (a) placing an RF power delivery electrode in contact with target tissue of a patient; (b) providing the tissue with a super-cooled fluid to cause a temporary cessation of cellular or electrical activity; (c) evaluating the effect of the distributed super-cooled fluid, including whether the providing of the super-cooled fluid to the target tissue causes a temporary cessation of cellular activity or electrical activity indicative of the disorder or tumor, or a temporary cessation of cellular activity or electrical activity indicative of a temporary adverse side effect; (d) providing the tissue with a conductive fluid to create a virtual electrode; (e) applying RF current to the tissue through the virtual electrode while continuing to provide conductive fluid to the tissue; (f) monitoring an impedance of the tissue; (g) determining a rate of change of the tissue impedance within a predetermined time interval; and (h) increasing a size of the virtual electrode when the determined rate of change of tissue impedance exceeds a predetermined value by increasing a flow rate of the conductive fluid.
Claim 20
Dependent Claim 61 words
The method of claim 8 and further including: determining a maximum impedance for the tissue to be ablated; determining an actual impedance at a specified time; comparing the maximum impedance with the actual impedance to determine if the actual impedance is greater than the maximum impedance; and reducing the applied power when the actual impedance is greater than the maximum impedance.
Claim 21
Dependent Claim 21 words
The method of claim 16 and further including adjusting the applied RF current power in response to the measured impedance change.
Claim 22
Dependent Claim 35 words
The method of claim 16 and further comprising: the step of monitoring the voltage to detect the occurrence of an electrical arc; and the step of reducing the power upon the detection of an arc.
Claim 23
Dependent Claim 25 words
The method of claim 19 and further including turning off the applied power upon the detection of an arc for a predetermined period of time.
Claim 24
Dependent Claim 28 words
The method of claim 16 and further including applying a RF current to the targeted tissue until permanent and complete coagulative necrosis of a target site is achieved.
Claim 25
Dependent Claim 24 words
The method of claim 16 , wherein the step of providing the tissue with the super-cooled fluid made via the RF power delivery electrode.
Claim 26
Dependent Claim 14 words
The method of claim 16 , wherein the tissue being treated is brain tissue.
Claim 27
Dependent Claim 21 words
The method of claim 23 , wherein the tissue being treated is of a patient experiencing a primary brain neurological disorder.
Claim 28
Dependent Claim 22 words
The method of claim 24 , wherein the primary brain neurological disorder is from the group consisting of epilepsy and Parkinson's disease.

USPTO Annuity & Maintenance Windows

Annuity Stage Window Opens Payment Deadline Surcharge Period Until Estimated Fee Status
3.5 Years (Year 4) 2006-03-24 2006-09-23 2007-03-25 $2000.00 Window Closed / Lapsed
7.5 Years (Year 8) 2010-03-24 2010-09-23 2011-03-25 $3760.00 Window Closed / Lapsed
11.5 Years (Year 12) 2014-03-24 2014-09-23 2015-03-25 $7700.00 Window Closed / Lapsed

Assigned Categories & Tags

No categories assigned to this patent yet.

Assign Category Tag